AKT1 and breast cancer: In the present study, we found that sorafenib induces apoptosis of BC cells via the activation and inactivation of PTEN and Akt pathways, respectively, thereby stimulating CB activity and Bid fragmentation, which induced the mitochondrial-dependent pathway of apoptosis.